Volume 16, Number 3—March 2010
Dispatch
Parvovirus 4–like Virus in Blood Products
Jozsef Szelei, Kaiyu Liu, Yi Li, Sandra Fernandes, and Peter Tijssen
Table 2
Analysis of relationships among the protein sequences of PARV4-like viruses*†
| Sequence | PARV4-p | PHoV | BHoV | PARV4-g1 | PARV4-g2 | PARV4-g3 |
|---|---|---|---|---|---|---|
| PARV4-p | ||||||
| NS | 99–100 | (99) | (80) | (68) | (68) | (68) |
| VP | 99–100 | (99) | (79) | (77) | (78) | (77) |
| SAT |
100 |
|||||
| PHoV | ||||||
| NS | 97–98 | 98–99 | (79) | (68) | (68) | (68) |
| VP | 99 | 99 | (79) | (77) | (77) | (77) |
| SAT |
98–100 |
98–100 |
||||
| BHoV | ||||||
| NS | 67–68 | 67 | 99 | (70) | (70) | (70) |
| VP | 66 | 66 | NA | (78) | (78) | (78) |
| SAT |
79 |
79 |
100 |
|||
| PARV4-g1 | ||||||
| NS | 53–55 | 53–54 | 56–57 | 96–99 | (99) | (98) |
| VP | 65 | 65 | 65 | 99 | (99) | (98–99) |
| SAT |
59 |
59 |
59 |
100 |
||
| PARV4-g2 | ||||||
| NS | 54–55 | 53–54 | 56 | 96–97 | 98–99 | (98) |
| VP | 65 | 65 | 64–65 | 98 | 98–99 | (98) |
| SAT |
59 |
59 |
59 |
100 |
100 |
|
| PARV4-g3 | ||||||
| NS | 54 | 53–54 | 56 | 96–97 | 96–97 | NA |
| VP | 65 | 65 | 64 | 98 | 97–98 | NA |
| SAT | 59 | 59 | 59 | 100 | 100 |
*PARV4, parvovirus type 4; PARV4-p, porcine PARV-4; PHoV, porcine hokovirus; BHoV, bovine hokovirus; PARV4-g1, PARV4 genotype 1; PARV4-g2, PARV4 genotype 2; PARV4-g3, PARV4 genotype 3; NS, nonstructural protein; VP, viral protein; NA, no alignment; SAT, small alternatively translated proteins.
†Numbers indicate percentages of amino acid sequence identity; numbers in parentheses indicate percentages of amino acid similarity (preserved physicochemical properties). Sequence similarity was not calculated for the SAT proteins, because of their relatively smaller size. When only 1 sequence was available (e.g., VP of BHoV), no alignment was performed.
Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.